Clinical trial
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
NCT00101751 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00101751 |
|---|---|
| Title | INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study |
| Official title | Efficacy and Safety of a Standard Titration Algorithm Coupled With a Conventional Dietary Intervention or Intensive Dietary Intervention Versus a Standard Titration Algorithm, Alone, in Patients With Type 2 Diabetes Initiating NovoLog® Mix 70/30 Therapy |
| Acronym | INITIATE plus |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Behavioral, Drug |
| Interventions | biphasic insulin aspart, dietary regimen |
| Enrollment | 4,877 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jan 13, 2005 |
| Last update posted | Nov 2, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: